Advertisement

GI & Endoscopy

The payer-provider relationship can be contentious. Here are 11 statistics on how gastroenterologists plan to interact with payers this year, according to the Medscape Gastroenterologist Compensation Report 2014.

A recent study published in the journal Clinical Gastroenterology and Hepatology, outlines three ways gastroenterologists can demonstrate value in the new healthcare continuum.

Advertisement

The FDA has approved ledipasvir/sofosbuvir (Harvoni), a combination anti-viral drug for the treatment of the hepatitis C virus, according to a Medscape report.

CMS has issued its final National Coverage Determination for the colorectal cancer stool DNA test Cologuard, developed by Exact Sciences.

Gastroenterologists are facing more and more demands on their time, while striving to maintain excellence. Four gastroenterologists share tips on improving GI practice efficiency without affecting quality of care.

Advertisement